Monitoring trustees, remedy and anti-trust advisors

CompetitionRx provides companies, advisors and regulatory authorities with extensive experience and authoritative advice on the:

As a monitoring trustee, CompetitionRx provides clients and competition authorities with a trustee and competition compliance team whose experience covers over 30 trustee apppointments and a very wide range of markets and countries, within and outside the EU.

We also bring to our trustee appointments a wide range of skills in; competition economics, regulatory processes, organisational change, business management, corporate governance, project management, corporate finance, M&A and the long-term monitoring of behavioural commitments.

Depending on the requirements of each case, our teams typically include highly experienced market, technical and national specialists.

The senior members of the CompetitionRx team are Dr Matthew Gaved, Thomas Hoehn, Michael Hubmann, Justin Menezes and Maurice de Valois Turk.

 Contact CompetitionRx

Les remèdes en contrôle des concentrations :
efficacité, suivi et respect des engagements

Thomas Hoehn, fondateur de CompetitionRx

Howard Shelanski, Professeur d'économie (Georgetown University)

Sophie Moonen, Chef d'unité f.f. (C5, DG COMP)

Emmanuel Frot, économètre, Microeconomix

Justin Menezes, directeur, CompetitionRx

François Lévêque, Professeur d'économie (Mines ParisTech),
associé fondateur de Microeconomix

Pascal Wilhelm, avocat

Matthew Gaved, fondateur de CompetitionRx

Fabien Zivy, Chef de service juridique de l'Autorité de la concurrence

 Copies of the presentations and articles based on these.

State Aid Restructuring Measures of Europe's Banks and the Financial Crisis
8 December 2011. Speakers:

Sophie Bertin-Hadjiveltcheva,
Head of Unit, State aids II – Task Force Financial Crisis, DG Competition;

Max Lienemeyer,
Deputy Head of Unit, State aids I – Task Force Financial Crisis, DG Competition;

Christoph Arhold,
Counsel, White & Case, Berlin, Brussels; and

François-Charles Laprévote,
Avocat, Cleary Gottlieb, Steen & Hamilton, Brussels.

  Presentations made by Christoph Arhold and François-Charles Laprévote.

Bundeskartellamt: Substantive Merger Control

The submission of CompetitionRx to the Bundeskartellamt in response to its 'Draft Guidance on Substantive Merger Control’ was made on 5 Oct 2011. Our submission raised ten specific issues which we believe should be considered by the Bundeskartellamt before publication of the final version of the Guidance.

 Read our submission to the Bundeskartellamt    Download the PDF version

EC: Quantifying damages in cartel cases

The submission of CompetitionRx to the European Commission in response to the EC's Draft Guidance Paper on the'Quantifying Harm in Actions for Damages Based on Breaches of Article 101 and 102 of the Treaty on the Functioning of the European Union’ was made on 30 Sept 2011.

 Read our submission to the European Commission    Download the PDF version